Asprosin Aggravates Tubular Epithelial Cell Injury and Phenotypic Transformation via Mitochondrial Dynamics Disorder Mediated by Excessive Drp1 SUMOylation in Diabetic Nephropathy Mice
Advanced Science · 2025
DOI: 10.1002/advs.202503259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Qianqian Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory of Drug Target Discovery and Validation, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Mitochondrial Dynamics, Dynamins, Epithelial Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangxi Province, Innovative Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Epidemiological studies show that some diabetic patients develop end‐stage renal dysfunction without significant proteinuria or glomerulopathy, underscoring the role of renal tubular epithelial cell (TEC) impairment in diabetic kidney disease (DKD). However, the primary pathogenic determinants underlying TEC impairment and disease advancement in DKD progression remain unclear. This study reveals that asprosin (ASP) is up‐regulated and positively correlated with kidney dysfunction in DKD mice. Moreover, elevated ASP is mainly located in the renal TEC, and negatively impacts TEC. In addition, supraphysiological ASP concentration impairs mitochondrial dynamics and function in both DKD mice and HK2 cells. Mechanistically, ASP promotes Drp1 over‐SUMOylation, thus reducing Drp1 degradation and disrupting mitochondrial dynamics homeostasis. However, the mutation of Drp1‐SUMOylation modification sites alleviates the mitochondrial dynamics disorder, TEC injury, and phenotypic transformation induced by ASP. Also, it is further elucidated that such a regulatory effect of ASP on the Drp1‐SUMOylation modification is fulfilled by modulating PIAS1 or SENP1 (a de‐SUMOylation protease). Importantly, either adipose tissue‐specific ASP deficiency (ASP −/− ) or ASP antibody (AASP) intervention significantly alleviates the kidney injury and mitochondrial dynamics disorder induced by STZ/HFD. These findings identify ASP as a novel predictor of DKD and offer new therapeutic strategies for DKD prevention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangxi Provincial Key Laboratory of Drug Target Discovery and Validation, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China.
- Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China.
ORCID-Profile: Qiren Huang
Förderung
- Natural Science Foundation of Jiangxi Province
- Innovative Research Group Project of the National Natural Science Foundation of China
Zitieren
APA
Huang, Q., Xiong, X., Chen, S., Wang, Y., Wang, L., Liu, W., Liu, C., Zeng, G., & Huang, Q. (2025). Asprosin Aggravates Tubular Epithelial Cell Injury and Phenotypic Transformation via Mitochondrial Dynamics Disorder Mediated by Excessive Drp1 SUMOylation in Diabetic Nephropathy Mice. Advanced Science. https://doi.org/10.1002/advs.202503259
Vancouver
Huang Q, Xiong X, Chen S, Wang Y, Wang L, Liu W, et al. Asprosin Aggravates Tubular Epithelial Cell Injury and Phenotypic Transformation via Mitochondrial Dynamics Disorder Mediated by Excessive Drp1 SUMOylation in Diabetic Nephropathy Mice. Advanced Science. 2025. doi:10.1002/advs.202503259
BibTeX
@article{Huang2025,
author = {Huang, Qianqian and Xiong, Xiaowei and Chen, Sheng and Wang, Yuan and Wang, Li and Liu, Wentao and Liu, Chen and Zeng, Guohua and Huang, Qiren},
title = {Asprosin Aggravates Tubular Epithelial Cell Injury and Phenotypic Transformation via Mitochondrial Dynamics Disorder Mediated by Excessive Drp1 SUMOylation in Diabetic Nephropathy Mice},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202503259}
}
EUVIMED